AnnElizabethWoolfreyMD

Clinical Trials

• Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Start of enrollment: 1999 Dec 01

  Completed

  Phase 2

• Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders Start of enrollment: 2000 Nov 01

  Completed

  Phase 1

• Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected With Human Immunodeficiency Virus-1 Using a Non-Marrow Ablative Conditioning Regimen Containing Total Body Irradiation in Combination Wi Start of enrollment: 2000 Nov 01
• Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder Start of enrollment: 2002 Jan 01

  Completed

  Phase 1, Phase 2

• Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01

  Completed

  Phase 3

• Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Start of enrollment: 2003 Apr 01

  Completed

  Phase 1, Phase 2

• Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer Start of enrollment: 1999 Nov 01

  Completed

  Not Applicable

• Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease Start of enrollment: 2003 Aug 01

  Completed

  Phase 1, Phase 2

• Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant Start of enrollment: 2006 Feb 01

  Terminated

  Phase 1

• Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases Start of enrollment: 2006 Dec 01

  Terminated

  Phase 2

• Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer Start of enrollment: 2007 Sep 01

  Terminated

  Phase 1, Phase 2

• Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer Start of enrollment: 2009 Dec 17

  Completed

  Phase 2

• Autologous Transplant in HIV Patients (BMT CTN 0803) Start of enrollment: 2010 Apr 01

  Completed

  Phase 2

• Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas Start of enrollment: 2010 Oct 06

  Completed

  Phase 1, Phase 2

• Selecting a Favorable KIR Donor in Unrelated HCT for AML Start of enrollment: 2011 Jun 01

  Completed

  Not Applicable

• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01

  Recruiting

• Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation Start of enrollment: 2012 Feb 01

  Recruiting

  Phase 2

• Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma Start of enrollment: 2015 Feb 01

  Withdrawn

  Not Applicable

• Join now to see all